Attend PACK EXPO – this year’s can’t-miss event in Chicago, Oct 23-26.
Discover solutions from 2,000+ exhibitors to advance your operations and network with colleagues at PACK EXPO International.
REGISTER TODAY

Recall Alert: Infant Liquid Ibuprofen, Part II

The recall of an infant pain reliever is snowballing due to concerns of dangerously high concentrations of the medication.

Infant Ibuprofen / Tril-Pharma
Infant Ibuprofen / Tril-Pharma

Back in December, we covered a story in which a popular infant ibuprofen was recalled due to concentration concerns. According to a January 30th NBC News article, the issue is far from resolved. Apparently the recall has expanded to include new lots of Tris-Pharma’s Infants’ Ibuprofen Concentrated Oral Suspension that may have higher concentrations than what appears on the label. Tests revealed that some units contained 10% more ibuprofen than listed.

“Studies have shown that safety issues or toxicity is generally accepted to be a concern in infants at doses in excess of 700 percent of the recommended dose. To date, no serious adverse events have been reported related to this recall,” Tris-Pharma said in a statement. Higher concentrations of ibuprofen could cause a host of issues including nausea, vomiting, diarrhea, stomach bleeding, and kidney damage.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts